President Joe Biden on May 5 threw his support behind waiving intellectual property rights for Covid-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies. Biden voiced his support for a waiver – a sharp reversal of the previous U.S. position – in remarks to reporters, followed swiftly by a statement from his top trade negotiator, Katherine Tai, who backed negotiations at the World Trade Organization.
The U.S. Centers for Disease Control and Prevention on April 2 said fully vaccinated people can safely travel at “low risk” after the agency had held off for weeks on revising guidance that discouraged all non-essential trips.
U.S. President Joe Biden secured a commitment from Pfizer Inc. to double the Covid-19 vaccine the company churns out in the coming weeks, putting his goal to fill the country’s inoculation stockpile by summer in sight.
Hours after being sworn in as the 46th President of the United States, Joe Biden signed 10 executive orders aimed at combating the ongoing Covid-19 crisis.
Joe Biden is resetting the United States’ response to the Covid-19 crisis after being sworn in as president to lead a country reeling from the nation’s worst public health crisis in more than a century.
AstraZeneca Plc’s cancer drug Imfinzi was approved in Europe and Britain for a spaced-out regimen in a common type of lung cancer to help reduce the frequency of hospital visits while continuing treatment.
Join TLD Group Advisor and Senior Consultant Dr. Kent Bottles in a webinar on December 3rd that will discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?
Six states reported record numbers of hospitalized Covid-19 patients, including Wisconsin, where officials issued a new order limiting the size of indoor public gatherings.
Novavax entered into an agreement to provide the United Kingdom with 60 million doses of the company’s Covid-19 vaccine candidate should NVX-CoV2373 be approved, as well as a late-stage efficacy study in the U.K.
Patients do not just want a doctor with a good bedside manner, according to new Everyday Health and Klick Health research exploring the growth of telemedicine and its increasing popularity with patients who continue to have healthcare needs, even in the midst of a pandemic and a socially distanced world.